Document Detail


Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids.
MedLine Citation:
PMID:  20974553     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This report examines the use of high-performance affinity chromatography as a screening tool for studying the change in binding by sulfonylurea drugs to the protein human serum albumin (HSA) during diabetes. The effects of both the non-enzymatic glycation of HSA and the presence of fatty acids on these interactions were considered using a zonal elution format. It was found that there was a significant increase (i.e., 2.7- to 3.6-fold) in the relative retention of several sulfonylurea drugs (i.e., acetohexamide, tolbutamide, glybenclamide and gliclazide) on columns containing normal versus glycated HSA. The addition of various long chain fatty acids to the mobile phase gave the same trend in retention for the tested drugs on both the HSA and glycated HSA columns, generally leading to lower binding. Most of the fatty acids examined produced similar or moderately different relative shifts in retention; however, palmitic acid was found to produce a much larger change in retention on columns containing glycated HSA versus normal HSA under the conditions used in this study.
Authors:
Sara B G Basiaga; David S Hage
Related Documents :
15476393 - Schistosoma mansoni fatty acid binding protein: specificity and functional control as r...
10526223 - Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: cd36, ...
18768163 - An evolutionary conserved d-galacturonic acid metabolic pathway operates across filamen...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-10-23
Journal Detail:
Title:  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences     Volume:  878     ISSN:  1873-376X     ISO Abbreviation:  J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-08     Completed Date:  2011-01-27     Revised Date:  2013-07-03    
Medline Journal Info:
Nlm Unique ID:  101139554     Medline TA:  J Chromatogr B Analyt Technol Biomed Life Sci     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  3193-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier B.V. All rights reserved.
Affiliation:
Chemistry Department, University of Nebraska, Lincoln, Lincoln, NE 68588-0304, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chromatography, Affinity / methods*
Diabetes Mellitus / drug therapy,  metabolism
Fatty Acids / chemistry*,  metabolism
Glycosylation
Humans
Hypoglycemic Agents / chemistry*,  metabolism
Kinetics
Protein Binding
Serum Albumin / chemistry*,  metabolism
Sulfonylurea Compounds / chemistry*,  metabolism
Grant Support
ID/Acronym/Agency:
R01 DK069629/DK/NIDDK NIH HHS; R01 DK069629-04/DK/NIDDK NIH HHS; RR015468/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Fatty Acids; 0/Hypoglycemic Agents; 0/Serum Albumin; 0/Sulfonylurea Compounds
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Determination of doxazosin and verapamil in human serum by fast LC-MS/MS: application to document no...
Next Document:  Reverse phase protein microarrays advance to use in clinical trials.